Summary
A method for preparation of autologous131J-tagged human fibrinogen is demonstrated.
In vitro the preparation is characterized by content of fibrinogen, protein, plasminogen, clottability and molecular weight. Total plasma radioactivity, specific radioactivity, non-protein-bound radioactivity, biologic half-life and the local activity at the thrombus define the properties in vivo.
With the above criteria autologous 131-J-tagged human fibrinogen was shown to be useful for early diagnosis of venous thrombosis.
Zusammenfassung
Es wird eine Herstellungsmethode von autologem131J-Humanfibrinogen angegeben.
Das Präparat wird charakterisiert in vitro durch Fibrinogengehalt, Proteingehalt, Plasminogengehalt, Gerinnbarkeit und Molekulargewicht der Einzelketten. In vivo werden Verlaufskurven der Gesamtplasmaaktivität, der spezifischen Aktivität, der nicht proteingebundenen Aktivität, der biologischen Halbwertszeit und des Verhaltens am Ort der Thrombose dargestellt.
An diesen Kriterien gemessen, erwies sich das autologe131J-Humanfibrinogen zur Thrombosefrühdiagnostik als voll geeignet.
Similar content being viewed by others
Literatur
Ardaillou, N., Larrieu, M.J.: In vitro studies of radiodinated fibrinogen. Comparison of the ICL and enzymatic methods. Thromb. Res.5, 327–341 (1974)
Blombäck, B., Blombäck, M.: Purification of human and bovine fibrinogen. Arkiv för Kemi10, 415–441 (1956)
Blombäck, B., Carlson, L.A., Franzen, S., Zetterqvist, E.: Turnover of131J-labelled fibrinogen in man. Acta Med. Scand.179, 557–574 (1966)
Bockslaff, H., Barthels, M., Stolle, E., Wuppermann, Th., Zech, G.: Frühdiagnose von Beinvenenthrombosen mit dem Radiofibrinogentest bei Patienten mit alloplastischem Hüftgelenksersatz. Münch. Med. Wschr.116, 1397–1404 (1974)
Bradley, J., Hickman, J.A.: Behaviour of commercially prepared J125 fibrinogen in metabolic studies. J. clin. Path.28, 487–493 (1975)
Browse, N.L., Clemenson, G.: Sequelae of an125J-fibrinogen detected thrombus. Brit. med. J.2, 468–470 (1974)
Coleman, R.E., Harwig, S.S.L., Harwig, J.F., Siegel, B.A., Welch, M.J.: Fibrinogen uptake by thrombi: Effect of thrombus age. J. Nucl. Med.16, 370–373 (1975)
Coleman, E., Harwig, S.S.L., Harwig, J.F., Sherman, L.A., Welch, M.J.: Radioiodinated soluble canine fibrin. Circ. Res.37, 35–40 (1975)
Coleman, E., Krohn, K.R., Metzger, J.M., Welch, M.J., Sekker-Walker, R.H., Siegel, B.A.: An in vivo evaluation of *J-fibrinogen labelled by four different methods. J. Lab. Clin. Med.83, 977–982 (1974)
Cohn, E.J., Strong, L.E., Hughes, W.L., jr., Milford, D.J., Ashworth, J.N., Melin, M., Taylor, H.L.: Preparation and properties of serum and plasma proteins IV J. Amer. Chem. Soc.68, 459–475 (1946)
Drapkin, A., Merskey, C.: Anticoagulant therapy after acute myocardial infarction. JAMA222, 541–546 (1972)
Edwards, D.H., Haynes, D.W.: Fate of125J-labelled fibrinogen. Lancet2, 220–221 (1974)
Fridrich, R., Schmitt, H.E., Madar, G., Widmer, L.K.: Radiofibrinogen-Test bei etablierter Venenthrombose. VASA3, 446–449 (1974)
Frisbie, J.H., O'Connell, D.J., Tow, D.E., Sasahara, A.A., Belko, J.S.: Autologous radioiodinated fibrinogen, simplified. J. Nucl. Med.16, 393–401 (1974)
Gordon-Smith, I.C., Grundy, D.J., Le Quesne, L.P., Newcombe, J.F., Bramble, F.J.: Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deepvein thrombosis. Lancet1, 1135 (1972)
Goudie, R.B., Lindsay, M.K., Pettigrew, N.M.: Safe use of125J-fibrinogen not proven. Lancet2, 1083–1084 (1973)
Hagan, P., Loberg, M.D., Rhodes, B.A., Harrison, K., Cooper, M.D.: “KIT” preparation of radioiodinated autologous fibrinogen using131J-monchloride. J. Nucl. Med.15, 974–980 (1974)
Hampson, W.G.J., Harris, F.C., Lucas, H.K., Roberts, P.H., McCall, I.W., Jackson, P.C., Powell, N.L., Staddon, G.E.: Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Lancet2, 795–797 (1974)
Hartsuck, J.M., Greenfield, L.J.: Postoperative thromboembolism. Arch. Surg.107, 733–739 (1973)
Harwig, S.S.L., Harwig, J.F., Coleman, R., Welch, M.J.: Effect of iodination level on the properties of radioiodinated fibrinogen. Thromb. Res.6, 375–386 (1975)
Harwig, J.F., Coleman, R.E., Harwig, S.S.L., Sherman, L.A., Siegel, B.A., Welch, M.J.: Highly iodinated fibrinogen: A new thrombus localizing agent. J. Nucl. Med.16, 756–763 (1975)
Hawker, R.J., Hawker, L.M., Wilkinson, G.A.L., Hamer, J.D.: Fate of 125-J-labelled fibrinogen. Lancet2, 1099–1100 (1975)
Hellerstein, H.K., Martin, J.W.: Incidence of thrombo-embolic lesions accompanying myocardial infarction. Am. Heart J.33, 443–452 (1947)
Hicks, B.H., Hazell, J.: Safe use of125J-fibrinogen. Lancet2, 931–934 (1973)
Hirsh, J., Gallus, A.S.:125J-labelled fibrinogen scanning. JAMA233, 970–973 (1975)
Hladovec, J., Prerovsky, I., Roztocil, K.: The influence of inflammation on the125J-fibrinogen uptake-test in experimental thrombosis. Angiologica10, 93–100 (1973)
Hobbs, J.T., Nicolaides, A.N.: The diagnosis of acute deep vein thrombosis with 125-iodinated fibrinogen. Aktuelle Probleme in der Angiologie 19, 205–213, Bern: Hans Huber Verlag 1973
Hörmann, H., Gollwitzer, R.: Analytische Untersuchungen über Rinderfibrinogen und-fibrin. Z. physiol. Chem.346, 21–41 (1966)
Hunter, W.M., Greenwood, F.C.: Preparation of Iodine-131 labelled human growth hormone of high specific activity. Nature194, 495–496 (1962)
Hume, M., Kuriakos, Tx., Jamieson, J.: Extent of venous thrombosis demonstrated by impedance and 125-J-fibrinogen leg scan. Amer. J. Surg.129, 455–458 (1975)
Jeyasingh, K., Maurer, B., Rosengarten, D.S., Verma, T.R.: Decline in blood activity of 125-J-fibrinogen in venous thrombosis. Lancet2, 294–295 (1970)
Kakkar, V.V., Corrigan, T.P.: Detection of deep vein thrombosis: Survey and current status. Progress in cardiovascular diseases XVII, 207–217 (1974)
Kerrigan, G.N.W., Buchanan, M.R., Cade, J.F., Regoeczi, E., Hirsh, J.: Investigation of the mechanism of false positive125J-labelled fibrinogen scans. Brit. J. Haematol.26, 469–473 (1974)
Kravis, T.C., Strubel, E.M., Brooks, J.D., Moser, K.M. and Moser, B.S.: Incorporation of radiolabelled fibrinogen into venous thrombi induced in dogs. Circulation59, 158–164 (1974)
Krohn, K.A., Sherman, L., Welch, M.J.: Studies on radioiodinated fibrinogen I. Physicochemical properties of the ICL, Chloramin T and electrolytic reaction products. Biochem. Biophys. Acta285, 404–413 (1972)
Krohn, K.A., Loberg, M.D., Welch, M.J.: A comparative study of five methods of production of radio-iodine labelled fibrinogen. Rad. Res.51, 501 (1972)
Ly, B., Kierulf, P.: Radioiodinated human fibrinogen. In vitro effects of increasing iodination. Thromb. Res.6, 387–398 (1975)
Maas, A.P.C. van der, Teulings, F.A.G., Schopman, W., den Ottolander, G.J.H.: The influence of acenorcumarole on the fibrinogen turnover in normal subjects, venous thrombosis and heart failure. Thromb. Diath. Haemorrh.28, 496–506 (1972)
Maurer, B.J., Wray, R., Shillingford, J.P.: Frequency of venous thrombosis after myocardial infarction. Lancet2, 1385–1387 (1971)
Mavor, G.E., Galloway, J.M.D.: The iliofemoral venous segment as a source of pulmonary emboli. Lancet1, 871–874 (1967)
McConahey, P.J., Dixon, F.J.: A method of trace iodination of proteins for immunologic studies. Int. Arch. Allergy29, 185–189 (1966)
McFarlane, A.S.: In vivo behavior of J-131-fibrinogen. J. Clin. Invest.42, 346–361 (1963)
Metzger, J.M., Secker-Walker, R.H., Krohn, K.A., Welch, M.J., Potchen, E.J.: Unsatisfactory biologic behavior of *J-fibrinogen labelled by the chloramine-T-method. J. Lab. Clin. Med.82, 267–275 (1973)
Morris, G.K., Henry, A.P.J., Preston, B.J.: Prevention of deepvein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet2, 797–800 (1974)
Mostbeck, A., Lofferer, O., Partsch, H.: Thrombosenachweis der unteren Extremitäten mit131J-Fibrinogen. Aktuelle Probleme in der Angiologie Bd. 19, S. 186–195, Bern: Hans Huber Verlag 1973
Murray, T.S., Lorimer, A.R., Cox, F.C., Lawrie, T.D.V.: Legvein thrombosis following myocardial infarction. Lancet2, 792–793 (1970)
Naegeli, Th., Matis, P., Gross, R., Runge, H., Sachs, H.W.: Die thrombembolischen Erkrankungen. Stuttgart: Schattauer Verlag 1960
Nanson, E.M., Palko, P.D., Dick, A.A., Fedoruk, S.O.: Early detection of deep venous thrombosis of the legs using J-131-tagged human fibrinogen: A clinical study. Ann. Surg.162, 438–445 (1965)
Negus, D., Pinto, D.J., Le Quesne, L.P., Brown, N., Chapman, M.: 125-J-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phleobography. Brit. J. Surg.55, 835–839 (1968)
Nicolaides, A.N., Kakkar, V.V., Renney, J.T.G., Kidner, P.H., Hutchison, D.C.S., Clarke, M.B.: Myocardial infarction and deep-vein thrombosis. Brit. med. J.1, 432–434 (1971)
O'Brien, J.R.: Detection of thrombosis with Jodine-125 fibrinogen, Lancet2, 396–399 (1970)
Olson, P.S., Ljungqvist, U., Bergentz, S.E.: Analysis of platelet, red cell and fibrin content in experimental arterial and venous thrombi. Thromb. Res.5, 1–19 (1974)
Partsch, H., Lofferer, O., Mostbeck, A.: Diagnosis of established deep-vein thrombosis in the leg using 131-J-fibrinogen. Angiology25, 719–728 (1974)
Pollak, E.W., Webber, M.M., Barker, W.F., Victery, W., Cragin, M., Witt, E.: Autologous 125-J-fibrinogen uptake test in the detection and management of venous thrombosis. Arch. Surg.109, 48–51 (1974)
Regoeczi, E.: Iodine-labelled fibrinogen: A review. Brit. J. Haematol.20, 649–663 (1971)
Regoeczi, E.: The clottability of iodinated fibrinogen. J. Nucl. Biol. Med.15, 37–41 (1971)
Roberts, R.C., Sonnentag, C.O., Frisbie, J.H.: Rapid preparation of autologous radioiodinated fibrinogen. J. Nucl. Med.13, 843–846 (1972)
Roberts, V.C.: Fibrinogen uptake scanning for diagnosis of deep vein thrombosis: A plea for standardization. Brit. med. J.3, 455–458 (1975)
Ruckley, C.V.: 125-J-fibrinogen test in diagnosis of deep vein thrombosis. Brit. med. J.2, 498–499 (1975)
Seifert, J., Gruber, U.F., Krumbach, J., Messmer, K.: 125-J-fibrinogen: Evaluation of different batches. Europ. Surg. Res.6, 123–125 (1974)
Schneider, W., Fischer, H.: Die chronisch-venöse Insuffizienz. Stuttgart: Ferdinand Enke Verlag 1969
Warlow, Ch., Terry, G., Kenmure, A.C.F., Beattie, A.G., Ogston, D., Douglas, A.S.: A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet2, 934–936 (1973)
Weber, K., Osborn, M.: The reliability of molecular weight determinations by dodecylsulfate-polyacrylamide gel electrophoresis. J. Biol. Chem.244, 4406–4412 (1969)
Wolf, E., Hume, M.: The semiquantitative classification of thrombus size by the 125-J-labelled fibrinogen technique. Thromb. Res.4, 757–767 (1974)
Zetterqvist, E.: Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Acta Physiol. Scand. Suppl.325, 1–41 (1969)
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.I.: Protein measurement with the folin phenol reagent. J. Biol. Chem.193, 265–275 (1951)
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft Wu 77/2
Rights and permissions
About this article
Cite this article
Wuppermann, T., Sippel, K. & Dahlgrün, H. Autologes131J-Humanfibrinogen zur Thrombosefrühdiagnostik. Klin Wochenschr 56, 437–443 (1978). https://doi.org/10.1007/BF01477057
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01477057